DOCSLIB.ORG

Activation of Recombinant Proenteropeptidase by Duodenase

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Activation of Recombinant Proenteropeptidase by Duodenase FEBS 23240 FEBS Letters 466 (2000) 295^299 Activation of recombinant proenteropeptidase by duodenase Tatyana S. Zamolodchikovaa;*, Elena A. Sokolovaa, Deshun Lub, J. Evan Sadlerc aShemyakin and Ovchinnikov Institute of Bioorganic Chemistry, RAS, 16/10 Miklukho-Maklaya, 117871, Moscow V-437, Russia bCardiovascular Research Division, Eli Lilly and Company, Indianapolis, IN 46285, USA cHoward Hughes Medical Institute, Washington University School of Medicine, St. Louis, MO, USA Received 13 December 1999 Edited by Vladimir Skulachev to suggest that duodenase belongs to the group of processing Abstract Duodenase, a serine proteinase from bovine Brunner's (duodenal) glands that was predicted to be a natural activator of enzymes. It was supposed that duodenase is the primary acti- enteropeptidase zymogen, cleaves and activates recombinant vator of proenteropeptidase [7]. 31 Enteropeptidase is a intrinsic membrane protein of enter- single-chain bovine proenteropeptidase (kcat/Km =2700 M s31). The measured rate of proenteropeptidase cleavage by ocytes of the proximal small intestine. The enzyme plays the duodenase was about 70-fold lower compared with the rate of key role in the digestive cascade, cleaving the N-terminal ac- trypsin-mediated cleavage of the zymogen. The role of duodenase tivation peptide from trypsinogen to produce trypsin, thereby is supposed to be the primary activator of proenteropeptidase leading to subsequent activation of other pancreatic zymogens maintaining a certain level of active enteropeptidase in the by trypsin [2]. Enteropeptidase is synthesized as single chain duodenum. A new scheme of proteolytic activation cascade of precursor which apparently undergoes proteolytic processing. digestive proteases is discussed. The questions concerning the mechanism of enteropeptidase z 2000 Federation of European Biochemical Societies. activation and the identi¢cation of the enzyme or enzymes Key words: Duodenase; Proenteropeptidase activation; responsible for proenteropeptidase processing has been a fo- Serine protease; Duodenal mucosa cus of many investigations [8^12]. The exclusive localization of duodenase in the duodenum, its high content in this tissue and its potential role in initiating of the activation cascade of digestive hydrolases (activation of 1. Introduction proenteropeptidase) permits to speculate the importance of duodenase in the function of the duodenum. The duodenum is the central part of the digestive system. To prove the role of this enzyme, we studied activation of Normal function of the duodenum is important for health. the recombinant single-chain bovine enteropeptidase precur- Digestion in the duodenum depends on various enzymatic sor by duodenase. processes in which numerous enzymes of pancreatic (trypsin, chymotrypsins, carboxypeptidases, kallikrein and elastase) 2. Materials and methods and intestinal origin take part. Pancreatic enzymes are synthe- sized as inactive forms and activated in the duodenum by a 2.1. Materials proteolytic cascade [1,2]. After hydrolysis by pancreatic pro- Recombinant proenteropeptidase and duodenase were prepared as teinases dietary proteins are metabolized by peptidases of the described previously [5,12]. Native bovine enteropeptidase was kindly mucosal epithelial cells into amino acids, which are absorbed provided by Dr. A.G. Mikhaylova (Shemyakin and Ovchinnikov In- stitute of Bioorganic Chemistry, Moscow, Russia). The chromogenic through the epithelium [3]. substrate glutamyl-glycyl-arginine 4-nitroanilide (Glu-Gly-Arg-pNA) A new proteolytic enzyme, duodenase, was discovered by us was kindly provided by Prof. V.A. Tkachuk (Cardiology Centre, in the bovine duodenal mucosa [4,5]. The primary structure of Moscow, Russia). The enteropeptidase substrate glycyl-tetra-aspar- the enzyme is related to that of chymases from mast cells, tyl-lysine L-naphthylamide (Gly-(Asp)4-Lys-NA) was purchased granzymes from cytotoxic T-lymphocytes and cathepsin G from Bachem, Germany. Bovine trypsin was from Miles Lab. Re- search Products, Republic of South Africa. Chicken egg white ovo- from leukocytes [6]. Nevertheless, duodenase has no relation mucoid was from Serva, Germany. Soybean trypsin inhibitor and to haemopoietic cells. It is the ¢rst protease localized in se- bovine trypsinogen were purchased from Sigma, USA. cretory granules of epitheliocytes in the Brunner's (duodenal) glands presented in the duodenal mucosa [7]. The enzyme as 2.2. Determination of the concentration and purity of the enzyme preparations constituent of the gland secrete enters duodenal slit and this Concentration of active duodenase was determined using titration suggests duodenase functions extracellularly. Duodenase has with soybean trypsin inhibitor as described earlier [7]; trypsin solution unique amino acid residues within its substrate binding pocket was titrated with p-nitrophenyl-p'-guanidinobenzoate [13]. Enzymatic [6], determining unusual speci¢city of the enzyme. The sub- purity of duodenase was con¢rmed by SDS^PAGE using substrate gel strate speci¢city of duodenase is dual: trypsin-like and chy- with co-polymerized azocasein [14]. Purity of duodenase and trypsin preparations used in the study was con¢rmed additionally by compar- motrypsin-like. However, it hydrolyzes protein substrates ative study of their proteolytic action on melittin and proinsulin [15]. yielding large and stable fragments [5]. This fact allows us 2.3. Successive activation of zymogens The usual method for assaying enteropeptidase by activation of *Corresponding author. Fax (7)-95-3107007. trypsinogen and subsequent measuring of the generated trypsin [16] E-mail: [email protected] was modi¢ed in our study. Recombinant proenteropeptidase (15 nM) was incubated with duodenase (13 nM) in 10 mM Tris^HCl, pH 8.0 at Abbreviations: -pNA, 4-nitroanilide; -NA, L-naphthylamide 37³C. Samples (5 Wl) were withdrawn after certain time periods and 0014-5793 / 00 / $20.00 ß 2000 Federation of European Biochemical Societies. All rights reserved. PII: S0014-5793(00)01092-9 FEBS 23240 21-1-00 296 T.S. Zamolodchikova et al./FEBS Letters 466 (2000) 295^299 added to 245 Wl of a reaction mixture containing trypsinogen (0.4 WM), vation by trypsin was decreased but not eliminated. The in- ovomucoid (4 WM), and 0.05 M CaCl2 in 0.1 M Na^acetate bu¡er crease of the trypsin activity in the analyzed samples was (pH 5.0). The control sample contained proenteropeptidase, trypsino- gen, and ovomucoid in the same bu¡er. The reaction mixture was proportional to the time of incubation of duodenase with incubated for 30 min at 37³C, and then 25 Wl of 1 M HCl were added proenteropeptidase, that con¢rmed activation of proentero- to achieve a ¢nal pH of 2.0 in order to inactivate enteropeptidase and peptidase by duodenase (Fig. 1A). However, in this assay dissociate the trypsin^ovomucoid complex. The activity of the formed design we were unable to determine the rate of proenteropep- trypsin was determined spectrophotometrically at 405 nm from hy- drolysis of Glu-Gly-Arg-pNA at 37³C. Trypsin-containing sample tidase activation by duodenase with su¤cient accuracy. (5 Wl) was added to the solution of the substrate (0.8 mM; 500 Wl) in 0.1 M Tris^HCl (pH 8.0), containing 0.05 M CaCl2. The hydrolysis 3.2. Determining the kcat/Km value of proenteropeptidase rate was measured from the initial slope of the charted curve. activation by duodenase To exclude the confounding e¡ect of trypsin-mediated 2.4. Direct monitoring of enteropeptidase activity Proenteropeptidase (38 nM) and duodenase (13 nM) were incu- cleavage of proenteropeptidase, the activation of proentero- bated at 37³C in 30 mM Tris^HCl, pH 8.0. At certain times, samples peptidase by duodenase was studied using a sensitive £uores- were withdrawn, and the reaction was stopped by adding soybean cent enteropeptidase substrate Gly-(Asp)4-Lys-NA. The time trypsin inhibitor to a ¢nal duodenase/inhibitor ratio of 1/10. Entero- course of proenteropeptidase (70 nM) activation by 5 nM peptidase activity was determined using the enteropeptidase substrate duodenase (Fig. 1B) indicated that generation of active en- Gly-(Asp)4-Lys-NA with a Hitachi 650-60 (Japan) £uorescence spec- trophotometer at 37³C. The reaction mixture (300 Wl) contained 0.1 M teropeptidase was linear over 4 h, and about 20% of the zy- Tris^HCl (pH 8.0), 0.05 M CaCl2, and 0.1 mM substrate. The reac- mogen was converted into the active enzyme. When the duo- tion was initiated by adding samples containing the activated entero- denase/proenteropeptidase molar ratio was increased to 1:3 peptidase. The concentration of liberated L-naphthylamine was deter- (duodenase concentration was 13 nM and proenteropeptidase mined from the £uorescence increment (Vex = 330 nm and Vem = 410 nm). concentration was 38 nM), about 90% of the precursors were The concentration of recombinant proenteropeptidase was assumed activated within 3 h. No autocatalytic cleavage or activation to be equal to the concentration of active enteropeptidase released was observed in the absence of duodenase. after total activation of proenteropeptidase by trypsin [12]. The concentrations of proenteropeptidase tested (up to 70 The k /K value was determined at the concentrations of proen- cat m nM) were not su¤cient to allow determination of k and K teropeptidase and duodenase of 70 nM and 5 nM, respectively, using cat m for cleavage of the zymogen by duodenase. Because the con- the equation v =(kcat/Km)[E]0[S], when [S]IKm [17]. All steps were performed as described above. The concentration of duodenase-acti- centration of proenteropeptidase in our experiments was vated enteropeptidase was calculated using the rate of liberation of L- much smaller than the predicted Km value for the duodenase naphthylamine and kinetic parameters of Gly-(Asp)4-Lys-NA hydro- cleavage ( s 1 WM), it was possible to estimate only the k / lysis by native enteropeptidase at pH 8.0 [18]. cat Km value using the equation v =(kcat/Km)[E]0[S] (when 2.5. Activation of proenteropeptidase: analysis by SDS^PAGE [S]IKm) [17]. The calculated kcat/Km value for duodenase The reaction mixture (8.5 Wl) contained recombinant proenteropep- activation of proenteropeptidase was 2700 M31 s31.
Load more

Recommended publications
  • Congenital Diarrheal Disorders: an Updated Diagnostic Approach
    4168 Int. J. Mol. Sci.2012, 13, 4168-4185; doi:10.3390/ijms13044168 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Congenital Diarrheal Disorders: An Updated Diagnostic Approach Gianluca Terrin 1, Rossella Tomaiuolo 2,3,4, Annalisa Passariello 5, Ausilia Elce 2,3, Felice Amato 2,3, Margherita Di Costanzo 5, Giuseppe Castaldo 2,3 and Roberto Berni Canani 5,6,* 1 Department of Gynecology-Obstetrics and Perinatal Medicine, University of Rome “La Sapienza”, Viale del Policlinico 1, Rome 00161, Italy; E-Mail: [email protected] 2 CEINGE-Advanced Biotechnology, Via Comunale Margherita, Naples 80131, Italy; E-Mails: [email protected] (R.T.); [email protected] (A.E.); [email protected] (F.A.); [email protected] (G.C.) 3 Department of Biochemistry and Biotechnology, University of Naples “Federico II”, Via Pansini 5, Naples 80131, Italy 4 Biotechnology Science, University of Naples “Federico II”, Via De Amicis, Naples 80131, Italy 5 Department of Pediatrics, University of Naples “Federico II”, Via Pansini 5, Naples 80131, Italy; E-Mails: [email protected] (A.P.); [email protected] (M.D.C.) 6 European Laboratory for the Investigation of Food Induced Diseases, University of Naples “Federico II”, Via Pansini 5, Naples 80131, Italy * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel./Fax: +39-0817462680. Received: 18 February 2012; in revised form: 2 March 2012 / Accepted: 19 March 2012 / Published: 29 March 2012 Abstract: Congenital diarrheal disorders (CDDs) are a group of inherited enteropathies with a typical onset early in the life.
    [Show full text]
  • 1 Evidence for Gliadin Antibodies As Causative Agents in Schizophrenia
    1 Evidence for gliadin antibodies as causative agents in schizophrenia. C.J.Carter PolygenicPathways, 20 Upper Maze Hill, Saint-Leonard’s on Sea, East Sussex, TN37 0LG [email protected] Tel: 0044 (0)1424 422201 I have no fax Abstract Antibodies to gliadin, a component of gluten, have frequently been reported in schizophrenia patients, and in some cases remission has been noted following the instigation of a gluten free diet. Gliadin is a highly immunogenic protein, and B cell epitopes along its entire immunogenic length are homologous to the products of numerous proteins relevant to schizophrenia (p = 0.012 to 3e-25). These include members of the DISC1 interactome, of glutamate, dopamine and neuregulin signalling networks, and of pathways involved in plasticity, dendritic growth or myelination. Antibodies to gliadin are likely to cross react with these key proteins, as has already been observed with synapsin 1 and calreticulin. Gliadin may thus be a causative agent in schizophrenia, under certain genetic and immunological conditions, producing its effects via antibody mediated knockdown of multiple proteins relevant to the disease process. Because of such homology, an autoimmune response may be sustained by the human antigens that resemble gliadin itself, a scenario supported by many reports of immune activation both in the brain and in lymphocytes in schizophrenia. Gluten free diets and removal of such antibodies may be of therapeutic benefit in certain cases of schizophrenia. 2 Introduction A number of studies from China, Norway, and the USA have reported the presence of gliadin antibodies in schizophrenia 1-5. Gliadin is a component of gluten, intolerance to which is implicated in coeliac disease 6.
    [Show full text]
  • Transplant Immunology
    Basic Immunology in Medical Practice น.พ. สกานต์ บุนนาค งานโรคไต กลุ่มงานอายุรศาสตร์ รพ.ราชวิถี Basic immunology • Innate immunity • Ready to be used • Less specificity • Comprise of • External barriers: skin, mucus, washing fluid etc. • Molecule: complement, acute-phase protein and cytokine • inflammatory mediator secreting cells: basophil, mast cell, eosinophil and natural killer cell • Phagocytic cells: neutrophil, monocyte, and macrophage Basis immunology • Adaptive immunity • Active after expose to specific Ag. • High specificity • Comprise of • Humoral immune response (HIR) : B lymphocyte, Memory B lymphocyte, plasma cell and antibody • Cell mediated immune response (CMIR) : T lymphocyte • Effector T lymphocyte • CD4+ T cell Helper T cell (Th1, Th2, Th17 etc.) • CD8+ T cell Cytotoxic T cell • Regulatory T lymphocyte • Memory T lymphocyte Innate immunity Cellular component of innate immunity • Activated by pathogen-associated molecular patterns (PAMPs) via pattern reconition receptors (PRRs). • PAMPs • Shared by a larged group of infectious agens • Unlikely to mutate • Clearly distinguishable from self pattern (commonly not present on mammalian cell surface • Gram-negative LPS, gram-positive lipoteichoic acid, yeast cell wall mannan etc. Phagocytic cells • Neutrophils, monocyte and macrophage • Killing machanisms • Reactive oxygen radicals • Oxygen-independent machanism: α – defencin, cathepsin G, lysozyme, lactoferin etc. Mast cells Mast cells Natural killer (NK) cells Activating NK-R FAS-L perforin FAS Granzyme-B Caspase cascade
    [Show full text]
  • Purification and Identification of a Binding Protein for Pancreatic
    Biochem. J. (2003) 372, 227–233 (Printed in Great Britain) 227 Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A Satoshi TSUZUKI*1,2,Yoshimasa KOKADO*1, Shigeki SATOMI*, Yoshie YAMASAKI*, Hirofumi HIRAYASU*, Toshihiko IWANAGA† and Tohru FUSHIKI* *Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan, and †Laboratory of Anatomy, Graduate School of Veterinary Medicine, Hokkaido University, Kita 18-Nishi 9, Kita-ku, Sapporo 060-0818, Japan Pancreatic secretory trypsin inhibitor (PSTI) is a potent trypsin of GzmA-expressing intraepithelial lymphocytes in the rat small inhibitor that is mainly found in pancreatic juice. PSTI has been intestine. We concluded that the PSTI-binding protein isolated shown to bind specifically to a protein, distinct from trypsin, on from the dispersed cells is GzmA that is produced in the the surface of dispersed cells obtained from tissues such as small lymphocytes of the tissue. The rGzmA hydrolysed the N-α- intestine. In the present study, we affinity-purified the binding benzyloxycarbonyl-L-lysine thiobenzyl ester (BLT), and the BLT protein from the 2 % (w/v) Triton X-100-soluble fraction of hydrolysis was inhibited by PSTI. Sulphated glycosaminoglycans, dispersed rat small-intestinal cells using recombinant rat PSTI. such as fucoidan or heparin, showed almost no effect on the Partial N-terminal sequencing of the purified protein gave a inhibition of rGzmA by PSTI, whereas they decreased the inhi- sequence that was identical with the sequence of mouse granzyme bition by antithrombin III.
    [Show full text]
  • Ige-Mediated Mast Cell Activation Promotes Inflammation And
    RESEARCH COMMUNICATION IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis Qian Wang1,2†, Christin M Lepus1,2†, Harini Raghu1,2†, Laurent L Reber3‡, Mindy M Tsai3, Heidi H Wong1,2, Ericka von Kaeppler1,2, Nithya Lingampalli1,2, Michelle S Bloom1,2, Nick Hu1,2, Eileen E Elliott1,2, Francesca Oliviero4, Leonardo Punzi4, Nicholas J Giori1,5, Stuart B Goodman5, Constance R Chu1,5, Jeremy Sokolove1,2, Yoshihiro Fukuoka6, Lawrence B Schwartz6, Stephen J Galli3,7, William H Robinson1,2* 1GRECC, VA Palo Alto Health Care System, Palo Alto, United States; 2Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, United States; 3Department of Pathology, Stanford University School of Medicine, Stanford, United States; 4Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy; 5Department of Orthopedic Surgery, Stanford University School of Medicine, Stanford, United States; 6Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, United States; 7Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States *For correspondence: [email protected] Abstract Osteoarthritis is characterized by articular cartilage breakdown, and emerging †These authors contributed evidence suggests that dysregulated innate immunity is likely involved. Here, we performed equally to this work proteomic, transcriptomic, and electron microscopic analyses to demonstrate that mast cells are Present address: ‡Center for aberrantly activated in human and murine osteoarthritic joint tissues. Using genetic models of mast Physiopathology of Toulouse- cell deficiency, we demonstrate that lack of mast cells attenuates osteoarthritis in mice. Using Purpan (CPTP), UMR 1043, genetic and pharmacologic approaches, we show that the IgE/FceRI/Syk signaling axis is critical for University of Toulouse, INSERM, the development of osteoarthritis.
    [Show full text]
  • Biological Function of Mast Cell Chymase
    Biological Function of Mast Cell Chymase In vitro and in vivo studies: a thorny pathway Elena Chugunova Department of Molecular Biosciences Uppsala Doctoral thesis Swedish University of Agricultural Sciences Uppsala 2004 Acta Universitatis Agriculturae Sueciae Veterinaria 181 ISSN 1401-6257 ISBN 91-576-6680-6 © 2004 Elena Chugunova, Uppsala Tryck: SLU Service/Repro, Uppsala 2004 Abstract Chugunova, E., 2004. Biological function of mast cell chymase mMCP-4. In vitro and in vivo studies: a thorny pathway. Doctor's dissertation. ISSN 1401-6257, ISBN 91-576-6680-6 Mast cells (MCs) are key effector cells in various types of inflammatory conditions. The MC secretory granules contain inflammatory mediators such as histamine, heparin proteoglycan (PG), cytokines and various heparin-binding proteases, including tryptases, chymases and carboxypeptidase A. Previously, a mouse strain with a defect in its heparin biosynthesis was produced by targeting the gene for NDST-2 (N-deacetylase/N-sulfotransferase-2). These mice showed reduced levels of MC inflammatory mediators such as histamine and various heparin- binding proteases, including chymases, tryptases, and carboxypeptidase A. By using this mouse strain, we found that chymase in complex with heparin PG degraded fibronectin, suggesting a role for chymase in the regulation of connective tissue composition. Further, we found that chymase/heparin PG complexes degraded and thereby inactivated both thrombin and plasmin, suggesting an additional role for chymase in regulation of extravascular coagulation and fibrinolysis. However, although our findings implicated chymase in these processes, it was not possible to exclude the contribution to the observed activities by other MC components that are influenced by the knockout of NDST-2.
    [Show full text]
  • Original Article
    Original Article Dipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes Potential Importance of Selectivity Over Dipeptidyl Peptidases 8 and 9 George R. Lankas,1 Barbara Leiting,2 Ranabir Sinha Roy,2 George J. Eiermann,3 Maria G. Beconi,4 Tesfaye Biftu,5 Chi-Chung Chan,6 Scott Edmondson,5 William P. Feeney,7 Huaibing He,5 Dawn E. Ippolito,3 Dooseop Kim,5 Kathryn A. Lyons,5 Hyun O. Ok,5 Reshma A. Patel,2 Aleksandr N. Petrov,3 Kelly Ann Pryor,2 Xiaoxia Qian,5 Leah Reigle,5 Andrea Woods,8 Joseph K. Wu,2 Dennis Zaller,8 Xiaoping Zhang,2 Lan Zhu,2 Ann E. Weber,5 and Nancy A. Thornberry2 Dipeptidyl peptidase (DPP)-IV inhibitors are a new ap- important to an optimal safety profile for this new class of proach to the treatment of type 2 diabetes. DPP-IV is a antihyperglycemic agents. Diabetes 54:2988–2994, 2005 member of a family of serine peptidases that includes quiescent cell proline dipeptidase (QPP), DPP8, and DPP9; DPP-IV is a key regulator of incretin hormones, but the functions of other family members are unknown. To deter- herapies that increase the circulating concentra- mine the importance of selective DPP-IV inhibition for the tions of insulin have proven beneficial in the treatment of diabetes, we tested selective inhibitors of DPP-IV, DPP8/DPP9, or QPP in 2-week rat toxicity studies treatment of type 2 diabetes. Dipeptidyl pepti- and in acute dog tolerability studies. In rats, the DPP8/9 Tdase (DPP)-IV inhibitors are a promising new inhibitor produced alopecia, thrombocytopenia, reticulocy- approach to type 2 diabetes that function, at least in part, topenia, enlarged spleen, multiorgan histopathological as indirect stimulators of insulin secretion (1).
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Elastase-Induced Pulmonary Emphysema: Insights from Experimental Models
    “main” — 2011/10/13 — 23:40 — page 1385 — #1 Anais da Academia Brasileira de Ciências (2011) 83(4): 1385-1395 (Annals of the Brazilian Academy of Sciences) Printed version ISSN 0001-3765 / Online version ISSN 1678-2690 www.scielo.br/aabc Elastase-induced pulmonary emphysema: insights from experimental models MARIANA A. ANTUNES and PATRICIA R.M. ROCCO Laboratório de Investigação Pulmonar, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Av. Carlos Chagas Filho, s/n, Cidade Universitária, Ilha do Fundão, 21941-902 Rio de Janeiro, RJ, Brasil Manuscript received on November 8, 2010; accepted for publication on May 19, 2011 ABSTRACT Several distinct stimuli can be used to reproduce histological and functional features of human emphysema, a lead- ing cause of disability and death. Since cigarette smoke is the main cause of emphysema in humans, experimental researches have attempted to reproduce this situation. However, this is an expensive and cumbersome method of em- physema induction, and simpler, more efficacious alternatives have been sought. Among these approaches, elastolytic enzymes have been widely used to reproduce some characteristics of human cigarette smoke-induced disease, such as: augmentation of airspaces, inflammatory cell influx into the lungs, and systemic inflammation. Nevertheless, theuse of elastase-induced emphysema models is still controversial, since the disease pathways involved in elastase induction may differ from those occurring in smoke-induced emphysema. This indicates that the choice of an emphysema model may impact the results of new therapies or drugs being tested. The aim of this review is to compare the mechanisms of disease induction in smoke and elastase emphysema models, to describe the differences among various elastase models, and to establish the advantages and disadvantages of elastase-induced emphysema models.
    [Show full text]
  • Extended Cleavage Specificities of Two Mast Cell Chymase-Related
    International Journal of Molecular Sciences Article Extended Cleavage Specificities of Two Mast Cell Chymase-Related Proteases and One Granzyme B-Like Protease from the Platypus, a Monotreme Zhirong Fu, Srinivas Akula , Michael Thorpe and Lars Hellman * Department of Cell and Molecular Biology, Uppsala University, Uppsala, The Biomedical Center, Box 596, SE-751 24 Uppsala, Sweden; [email protected] (Z.F.); [email protected] (S.A.); [email protected] (M.T.) * Correspondence: [email protected]; Tel.: +46-(0)18-471-4532; Fax: +46-(0)18-471-4862 Received: 20 November 2019; Accepted: 31 December 2019; Published: 2 January 2020 Abstract: Mast cells (MCs) are inflammatory cells primarily found in tissues in close contact with the external environment, such as the skin and the intestinal mucosa. They store large amounts of active components in cytoplasmic granules, ready for rapid release. The major protein content of these granules is proteases, which can account for up to 35 % of the total cellular protein. Depending on their primary cleavage specificity, they can generally be subdivided into chymases and tryptases. Here we present the extended cleavage specificities of two such proteases from the platypus. Both of them show an extended chymotrypsin-like specificity almost identical to other mammalian MC chymases. This suggests that MC chymotryptic enzymes have been conserved, both in structure and extended cleavage specificity, for more than 200 million years, indicating major functions in MC-dependent physiological processes. We have also studied a third closely related protease, originating from the same chymase locus whose cleavage specificity is closely related to the apoptosis-inducing protease from cytotoxic T cells, granzyme B.
    [Show full text]
  • Like Transmembrane Γ Evolved From
    Mast Cell α and β Tryptases Changed Rapidly during Primate Speciation and Evolved from γ-Like Transmembrane Peptidases in Ancestral Vertebrates This information is current as of September 25, 2021. Neil N. Trivedi, Qiao Tong, Kavita Raman, Vikash J. Bhagwandin and George H. Caughey J Immunol 2007; 179:6072-6079; ; doi: 10.4049/jimmunol.179.9.6072 http://www.jimmunol.org/content/179/9/6072 Downloaded from References This article cites 34 articles, 15 of which you can access for free at: http://www.jimmunol.org/content/179/9/6072.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 25, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Mast Cell ␣ and ␤ Tryptases Changed Rapidly during Primate Speciation and Evolved from ␥-Like Transmembrane Peptidases in Ancestral Vertebrates1 Neil N. Trivedi, Qiao Tong, Kavita Raman, Vikash J. Bhagwandin, and George H.
    [Show full text]
  • Enzymes for Cell Dissociation and Lysis
    Issue 2, 2006 FOR LIFE SCIENCE RESEARCH DETACHMENT OF CULTURED CELLS LYSIS AND PROTOPLAST PREPARATION OF: Yeast Bacteria Plant Cells PERMEABILIZATION OF MAMMALIAN CELLS MITOCHONDRIA ISOLATION Schematic representation of plant and bacterial cell wall structure. Foreground: Plant cell wall structure Background: Bacterial cell wall structure Enzymes for Cell Dissociation and Lysis sigma-aldrich.com The Sigma Aldrich Web site offers several new tools to help fuel your metabolomics and nutrition research FOR LIFE SCIENCE RESEARCH Issue 2, 2006 Sigma-Aldrich Corporation 3050 Spruce Avenue St. Louis, MO 63103 Table of Contents The new Metabolomics Resource Center at: Enzymes for Cell Dissociation and Lysis sigma-aldrich.com/metpath Sigma-Aldrich is proud of our continuing alliance with the Enzymes for Cell Detachment International Union of Biochemistry and Molecular Biology. Together and Tissue Dissociation Collagenase ..........................................................1 we produce, animate and publish the Nicholson Metabolic Pathway Hyaluronidase ...................................................... 7 Charts, created and continually updated by Dr. Donald Nicholson. DNase ................................................................. 8 These classic resources can be downloaded from the Sigma-Aldrich Elastase ............................................................... 9 Web site as PDF or GIF files at no charge. This site also features our Papain ................................................................10 Protease Type XIV
    [Show full text]